Free Alerts   Login
Health Care › Wholesale-Medical, Dental And Hospital Equipment And Supplies

OMI Stock Price Correlated With Owens & Minor Financials

OMI Stock Price vs. Quarterly
OMI
Income Statement
Cash Flow
Balance Sheet

OMI Income Statement

Enable JavaScript and reload
Revenue, Net:
Revenue Per Share:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
Earnings Per Share, Diluted:
Earnings Per Share, Basic:
Shares Outstanding, Basic Avg:
Shares Outstanding, Diluted Avg:
Common Stock Shares Outstanding:

OMI Cash Flow

Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Net Cash from Operations Per Share:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:

OMI Balance Sheet

Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Inventories:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Blackrock.
12,273,657 sh
469,421 sh
4%
$236,513
$45,756
FMR
10,431,010 sh
-1,048,199 sh
-9%
$201,005
$15,500
Vanguard Group
8,587,684 sh
-5,220 sh
0%
$165,485
$26,623
Deerfield Management Company, L.P. (Series C)
5,229,779 sh
-1,205,221 sh
-19%
$100,778
-$3,212
Pacer Advisors.
5,221,081 sh
1,903,266 sh
57%
$100,610
$46,994
Dimensional Fund Advisors
4,210,991 sh
327,002 sh
8%
$81,148
$18,382
State Street
3,126,191 sh
46,748 sh
2%
$60,242
$10,478
Wellington Management Group Llp
2,111,493 sh
-2,513,269 sh
-54%
$40,689
-$34,047
Janus Henderson Group Plc
2,073,828 sh
-252,335 sh
-11%
$39,964
$2,373
D. E. Shaw & Co..
1,704,874 sh
139,088 sh
9%
$32,853
$7,550
Geode Capital Management
1,606,989 sh
73,891 sh
5%
$30,970
$6,192
Renaissance Technologies
1,306,971 sh
168,471 sh
15%
$25
$7
Invesco.
1,155,598 sh
74,138 sh
7%
$22,268
$4,792
Nuveen Asset Management
1,104,049 sh
-183,964 sh
-14%
$21,275
$461
Morgan Stanley
984,544 sh
172,983 sh
21%
$18,972
$5,859
Northernrp
912,292 sh
611 sh
0%
$17,580
$2,848
Charles Schwab Investment Management
825,142 sh
38,393 sh
5%
$15,900
$3,186
Bank Of New York Mellon
702,670 sh
-55,970 sh
-7%
$13,541
$1,280
Voloridge Investment Management
627,727 sh
383,728 sh
157%
$12,096
$8,153
Bridgeway Capital Management
528,665 sh
24,853 sh
5%
$10,187
$2,045
COMPANY PROFILE
Summary of Significant Accounting Policies Basis of Presentation

The accompanying unaudited consolidated financial statements include the accounts of Owens & Minor, Inc. and the subsidiaries it controls (we, us, our or the Company) and contain all adjustments (which are comprised only of normal recurring accruals and use of estimates) necessary to conform with U.S. generally accepted accounting principles (GAAP). All significant intercompany accounts and transactions have been eliminated. The results of operations for interim periods are not necessarily indicative of the results expected for the full year.

To better reflect how we go to market as well as certain changes to the leadership team, organizational structure, budgeting and financial reporting processes which drive changes to segment reporting, we have organized our business into two distinct segments: Products & Healthcare Services and Patient Direct. Products & Healthcare Services provides distribution, outsourced logistics and value-added services, and manufactures and sources medical surgical products through our production and kitting operations. Patient Direct expands our business along the continuum of care through delivery of disposable medical supplies sold directly to patients and home health agencies and is a leading provider of integrated home healthcare equipment and related services in the United States. Beginning with the quarter ended March 31, 2022, we now report financial results using this two segment structure and have recast prior year segment results on the same basis.

On March 29, 2022, we completed the acquisition of 100% of Apria, Inc. pursuant to the Agreement and Plan of Merger dated January 7, 2022, in exchange for approximately $1.7 billion, net of cash acquired. Refer to Note 3 for additional details.

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year presentation.

Use of Estimates

The preparation of consolidated financial statements in conformity with GAAP requires us to make assumptions and estimates that affect reported amounts and related disclosures. Actual results may differ from these estimates.

Cash, Cash Equivalents and Restricted Cash

Cash, cash equivalents and restricted cash includes cash and marketable securities with an original maturity or maturity at acquisition of three months or less. Cash, cash equivalents and restricted cash are stated at cost. Nearly all of our cash, cash equivalents and restricted cash are held in cash depository accounts in major banks in the United States, Europe, and Asia. Cash that is held by a major bank and has restrictions on its availability to us is classified as restricted cash. Restricted cash included in Other assets, net as of March 31, 2022 and December 31, 2021 primarily represents cash held in an escrow account as required by the Centers for Medicare & Medicaid Services (CMS) in conjunction with the Bundled Payments for Care Improvement (BPCI) initiatives related to wind-down costs of Fusion5.

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the accompanying consolidated balance sheets that sum to the total of those same amounts presented in the accompanying consolidated statements of cash flows.

March 31, 2022 December 31, 2021 Cash and cash equivalents $ 211,298 $ 55,712 Restricted cash included in Other assets, net 16,725 16,323 Total cash, cash equivalents, and restricted cash $ 228,023 $ 72,035

Patient Equipment

Patient equipment, which is included within property and equipment, net, is stated at cost less depreciation and reserves for non-recoverable and obsolete patient equipment. Patient equipment consists of medical equipment rented to patients on a month-to-month basis. Patient equipment is generally placed for rent; however, it could also be sold to customers. Once the rented equipment is returned to us, the patient equipment is assessed and repaired as ne

Free historical financial statements for Owens & Minor Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 52 quarters since 2011. Compare with OMI stock chart to see long term trends.

Data imported from Owens & Minor Inc. SEC filings. Check original filings before making any investment decision.